Literature DB >> 17670746

High glucose increases angiopoietin-2 transcription in microvascular endothelial cells through methylglyoxal modification of mSin3A.

Dachun Yao1, Tetsuya Taguchi, Takeshi Matsumura, Richard Pestell, Diane Edelstein, Ida Giardino, Guntram Suske, Naila Rabbani, Paul J Thornalley, Vijay P Sarthy, Hans-Peter Hammes, Michael Brownlee.   

Abstract

Methylglyoxal is a highly reactive dicarbonyl degradation product formed from triose phosphates during glycolysis. Methylglyoxal forms stable adducts primarily with arginine residues of intracellular proteins. The biologic role of this covalent modification in regulating cell function is not known. Here we report that in mouse kidney endothelial cells, high glucose causes increased methylglyoxal modification of the corepressor mSin3A. Methylglyoxal modification of mSin3A results in increased recruitment of O-GlcNAc-transferase, with consequent increased modification of Sp3 by O-linked N-acetylglucosamine. This modification of Sp3 causes decreased binding to a glucose-responsive GC-box in the angiopoietin-2 (Ang-2) promoter, resulting in increased Ang-2 expression. Increased Ang-2 expression induced by high glucose increased expression of intracellular adhesion molecule 1 and vascular cell adhesion molecule 1 in cells and in kidneys from diabetic mice and sensitized microvascular endothelial cells to the proinflammatory effects of tumor necrosis factor alpha. This novel mechanism for regulating gene expression may play a role in the pathobiology of diabetic vascular disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17670746     DOI: 10.1074/jbc.M704703200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  88 in total

Review 1.  The roles of O-linked β-N-acetylglucosamine in cardiovascular physiology and disease.

Authors:  Natasha E Zachara
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-01-27       Impact factor: 4.733

2.  Glycation-altered proteolysis as a pathobiologic mechanism that links dietary glycemic index, aging, and age-related disease (in nondiabetics).

Authors:  Tomoaki Uchiki; Karen A Weikel; Wangwang Jiao; Fu Shang; Andrea Caceres; Dorota Pawlak; James T Handa; Michael Brownlee; Ram Nagaraj; Allen Taylor
Journal:  Aging Cell       Date:  2011-11-15       Impact factor: 9.304

3.  Identification of microRNA-93 as a novel regulator of vascular endothelial growth factor in hyperglycemic conditions.

Authors:  Jianyin Long; Yin Wang; Wenjian Wang; Benny H J Chang; Farhad R Danesh
Journal:  J Biol Chem       Date:  2010-05-25       Impact factor: 5.157

Review 4.  Protein O-GlcNAcylation in diabetes and diabetic complications.

Authors:  Junfeng Ma; Gerald W Hart
Journal:  Expert Rev Proteomics       Date:  2013-08       Impact factor: 3.940

5.  Growth factors/chemokines in diabetic vitreous and aqueous alter the function of bone marrow-derived progenitor (CD34⁺) cells in humans.

Authors:  Sankarathi Balaiya; Maria B Grant; Joshua Priluck; Kakarla V Chalam
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-08-26       Impact factor: 4.310

6.  Combined Antibody/Lectin Enrichment Identifies Extensive Changes in the O-GlcNAc Sub-proteome upon Oxidative Stress.

Authors:  Albert Lee; Devin Miller; Roger Henry; Venkata D P Paruchuri; Robert N O'Meally; Tatiana Boronina; Robert N Cole; Natasha E Zachara
Journal:  J Proteome Res       Date:  2016-10-14       Impact factor: 4.466

7.  The Role of the O-GlcNAc Modification in Regulating Eukaryotic Gene Expression.

Authors:  Sandii Brimble; Edith E Wollaston-Hayden; Chin Fen Teo; Andrew C Morris; Lance Wells
Journal:  Curr Signal Transduct Ther       Date:  2010

Review 8.  The role of O-GlcNAc signaling in the pathogenesis of diabetic retinopathy.

Authors:  Richard D Semba; Hu Huang; Gerard A Lutty; Jennifer E Van Eyk; Gerald W Hart
Journal:  Proteomics Clin Appl       Date:  2014-02-19       Impact factor: 3.494

Review 9.  Site-specific AGE modifications in the extracellular matrix: a role for glyoxal in protein damage in diabetes.

Authors:  Paul Voziyan; Kyle L Brown; Sergei Chetyrkin; Billy Hudson
Journal:  Clin Chem Lab Med       Date:  2014-01-01       Impact factor: 3.694

10.  Oral benfotiamine plus alpha-lipoic acid normalises complication-causing pathways in type 1 diabetes.

Authors:  X Du; D Edelstein; M Brownlee
Journal:  Diabetologia       Date:  2008-07-29       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.